AegirBio AB Statistics
Want to see SE:SUBGEN full AI Analyst Report?
AegirBio AB (SUBGEN) Stock Statistics & Valuation Metrics
Total Valuation
AegirBio AB has a market cap or net worth of SEK 67.05M. The enterprise value is SEK 474.34M.
- Market Cap
- SEK 67.05M
- Enterprise Value
- SEK 474.34M
Share Statistics
AegirBio AB has 1,736,062,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,736,062,300
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
AegirBio AB’s return on equity (ROE) is -0.21 and return on invested capital (ROIC) is -23.04%.
- Return on Equity (ROE)
- -0.21
- Return on Assets (ROA)
- -0.14
- Return on Invested Capital (ROIC)
- -23.04%
- Return on Capital Employed (ROCE)
- -0.26
- Revenue Per Employee
- 814.29K
- Profits Per Employee
- -354.09K
- Employee Count
- 251
- Asset Turnover
- 0.33
- Inventory Turnover
- 6.54
Valuation Ratios
The current PE Ratio of AegirBio AB is -0.29. AegirBio AB’s PEG ratio is -0.00.
- PE Ratio
- -0.29
- PS Ratio
- 0.00
- PB Ratio
- 0.09
- Price to FCF
- -0.01
- Price to Operating Cash Flow
- 2.35
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, AegirBio AB had revenue of 204.39M and earned -88.88M in profits. Earnings per share was -0.41.
- Revenue
- 204.39M
- Gross Profit
- 75.16M
- Operating Income
- -129.21M
- Pretax Income
- -90.00M
- Net Income
- -88.88M
- EBITDA
- -104.63M
- Earnings Per Share (EPS)
- -0.41
Cash Flow
In the last 12 months, operating cash flow was 17.59M and capital expenditures -24.43M, giving a free cash flow of -6.84M billion.
- Operating Cash Flow
- 17.59M
- Free Cash Flow
- -6.84M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
AegirBio AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -8127.99%
- Earnings Yield
- -291.25%
Stock Price Statistics
- Beta
- 5.55
- 52-Week Price Change
- -99.75%
- 50-Day Moving Average
- 0.03
- 200-Day Moving Average
- 0.11
- Relative Strength Index (RSI)
- 43.48
- Average Volume (3m)
- 21.12M
Important Dates
AegirBio AB upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Mar 31, 2027
- Ex-Dividend Date
- ―
Financial Position
AegirBio AB as a current ratio of 0.75, with Debt / Equity ratio of 24.46%
- Current Ratio
- 0.75
- Quick Ratio
- 0.59
- Debt to Market Cap
- 655.38
- Net Debt to EBITDA
- -0.80
- Interest Coverage Ratio
- -7.73
Taxes
In the past 12 months, AegirBio AB has paid -1.12M in taxes.
- Income Tax
- -1.12M
- Effective Tax Rate
- 0.01
Enterprise Valuation
AegirBio AB EV to EBITDA ratio is -1.71, with an EV/FCF ratio of -32.31.
- EV to Sales
- 1.03
- EV to EBITDA
- -1.71
- EV to Free Cash Flow
- -32.31
- EV to Operating Cash Flow
- 12.56
Balance Sheet
AegirBio AB has SEK 19.51M in cash and marketable securities with SEK 240.41M in debt, giving a net cash position of -SEK 220.90M billion.
- Cash & Marketable Securities
- SEK 19.51M
- Total Debt
- SEK 240.41M
- Net Cash
- -SEK 220.90M
- Net Cash Per Share
- -SEK 0.13
- Tangible Book Value Per Share
- SEK 0.01
Margins
Gross margin is 34.47%, with operating margin of -73.94%, and net profit margin of -56.29%.
- Gross Margin
- 34.47%
- Operating Margin
- -73.94%
- Pretax Margin
- -69.97%
- Net Profit Margin
- -56.29%
- EBITDA Margin
- -59.89%
- EBIT Margin
- -74.05%
Scores
- Smart Score
- ―
- AI Score
- 41
